• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学研究中的虚假事实与另类真相。

Fake facts and alternative truths in medical research.

作者信息

Hofmann Bjørn

机构信息

The Institute for the Health Sciences, Norwegian University of Science and Technology (NTNU), PO Box 1, N-2802, Gjøvik, Norway.

Centre for Medical Ethics, University of Oslo, Oslo, Norway.

出版信息

BMC Med Ethics. 2018 Jan 27;19(1):4. doi: 10.1186/s12910-018-0243-z.

DOI:10.1186/s12910-018-0243-z
PMID:29374485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5787277/
Abstract

BACKGROUND

Fake news and alternative facts have become commonplace in these so-called "post-factual times." What about medical research - are scientific facts fake as well? Many recent disclosures have fueled the claim that scientific facts are suspect and that science is in crisis. Scientists appear to engage in facting interests instead of revealing interesting facts. This can be observed in terms of what has been called polarised research, where some researchers continuously publish positive results while others publish negative results on the same issue - even when based on the same data. In order to identify and address this challenge, the objective of this study is to investigate how polarised research produce "polarised facts." Mammography screening for breast cancer is applied as an example.

MAIN BODY

The main benefit with mammography screening is the reduced breast cancer mortality, while the main harm is overdiagnosis and subsequent overtreatment. Accordingly, the Overdiagnosis to Mortality Reduction Ratio (OMRR) is an estimate of the risk-benefit-ratio for mammography screening. As there are intense interests involved as well as strong opinions in debates on mammography screening, one could expect polarisation in published results on OMRR. A literature search identifies 8 studies publishing results for OMRR and reveals that OMRR varies 25-fold, from 0.4 to 10. Two experts in polarised research were asked to rank the attitudes of the corresponding authors to mammography screening of the identified publications. The results show a strong correlation between the OMRR and the authors' attitudes to screening (R = 0.9).

CONCLUSION

Mammography screening for breast cancer appears as an exemplary field of strongly polarised research. This is but one example of how scientists' strong professional interests can polarise research. Instead of revealing interesting facts researchers may come to fact interests. In order to avoid this and sustain trust in science, researchers should disclose professional and not only financial interests when submitting and publishing research.

摘要

背景

在这些所谓的“后事实时代”,假新闻和另类事实已变得司空见惯。医学研究又如何呢——科学事实也是假的吗?最近的许多披露加剧了一种说法,即科学事实值得怀疑,科学正处于危机之中。科学家似乎在追求利益而非揭示有趣的事实。这在所谓的两极分化研究中可见一斑,即一些研究人员不断发表积极结果,而另一些研究人员在同一问题上发表消极结果——即使是基于相同的数据。为了识别并应对这一挑战,本研究的目的是调查两极分化的研究如何产生“两极分化的事实”。以乳腺癌的乳房X线筛查为例。

主体

乳房X线筛查的主要益处是降低乳腺癌死亡率,而主要危害是过度诊断及随后的过度治疗。因此,过度诊断与死亡率降低比率(OMRR)是乳房X线筛查风险效益比的一种估计。由于在乳房X线筛查的辩论中涉及强烈的利益以及强烈的观点,人们可能会预期关于OMRR的已发表结果会出现两极分化。一项文献检索找出了8项发表OMRR结果的研究,并显示OMRR的变化幅度达25倍,从0.4到10。两位两极分化研究方面的专家被要求对已识别出版物的相应作者对乳房X线筛查的态度进行排名。结果显示OMRR与作者对筛查的态度之间存在很强的相关性(R = 0.9)。

结论

乳腺癌的乳房X线筛查似乎是两极分化研究的一个典型领域。这只是科学家强烈的职业利益如何使研究两极分化的一个例子。研究人员可能会追求利益而非揭示有趣的事实。为了避免这种情况并维持对科学的信任,研究人员在提交和发表研究时应披露职业利益,而不仅仅是经济利益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc4/5787277/5ccbc637c643/12910_2018_243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc4/5787277/5ccbc637c643/12910_2018_243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc4/5787277/5ccbc637c643/12910_2018_243_Fig1_HTML.jpg

相似文献

1
Fake facts and alternative truths in medical research.医学研究中的虚假事实与另类真相。
BMC Med Ethics. 2018 Jan 27;19(1):4. doi: 10.1186/s12910-018-0243-z.
2
Mammography screening: A major issue in medicine.乳腺 X 光筛查:医学中的一个重大问题。
Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20.
3
4
Screening mammography: update and review of publications since our report in the New England Journal of Medicine on the magnitude of the problem in the United States.乳腺钼靶筛查:自我们在《新英格兰医学杂志》上发表关于美国该问题严重程度的报告以来的出版物更新与综述。
Acad Radiol. 2015 Aug;22(8):949-60. doi: 10.1016/j.acra.2015.03.003. Epub 2015 Jun 19.
5
Conclusions in systematic reviews of mammography for breast cancer screening and associations with review design and author characteristics.关于乳腺癌筛查的乳腺X线摄影系统评价中的结论以及与评价设计和作者特征的关联。
Syst Rev. 2017 May 22;6(1):105. doi: 10.1186/s13643-017-0495-6.
6
Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.因乳腺 X 光筛查导致的必然过度诊断:美国女性的直接评估
Radiology. 2018 May;287(2):391-397. doi: 10.1148/radiol.2017171622. Epub 2017 Dec 21.
7
Mammography screening. Benefits, harms, and informed choice.乳腺钼靶筛查:益处、危害与明智选择
Dan Med J. 2013 Apr;60(4):B4614.
8
Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer.当前乳腺癌过度诊断和过度治疗的问题。
AJR Am J Roentgenol. 2018 Feb;210(2):285-291. doi: 10.2214/AJR.17.18629. Epub 2017 Nov 1.
9
[Overdiagnosis in mammography screening for breast cancer].[乳腺癌钼靶筛查中的过度诊断]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Nov 10;38(11):1574-1578. doi: 10.3760/cma.j.issn.0254-6450.2017.11.027.
10
Breast cancer screening: Where have we been and where are we going? A personal perspective based on history, data and experience.乳腺癌筛查:我们走过了哪些历程,又将走向何方?基于历史、数据和经验的个人观点。
Clin Imaging. 2018 Mar-Apr;48:vii-xi. doi: 10.1016/j.clinimag.2017.12.016.

引用本文的文献

1
To Consent or Not to Consent to Screening, That Is the Question.同意还是不同意筛查,这是个问题。
Healthcare (Basel). 2023 Mar 30;11(7):982. doi: 10.3390/healthcare11070982.
2
Fake news detection: A survey of graph neural network methods.假新闻检测:图神经网络方法综述
Appl Soft Comput. 2023 May;139:110235. doi: 10.1016/j.asoc.2023.110235. Epub 2023 Mar 24.
3
Online information about mammography screening in Italy from 2014 to 2021.2014 年至 2021 年意大利关于乳腺 X 光筛查的在线信息。

本文引用的文献

1
Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.主要研究者的经济利益关系与随机对照试验结果:横断面研究
BMJ. 2017 Jan 17;356:i6770. doi: 10.1136/bmj.i6770.
2
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses.冗余、误导性及存在冲突的系统评价和Meta分析的大量产出。
Milbank Q. 2016 Sep;94(3):485-514. doi: 10.1111/1468-0009.12210.
3
Balancing the benefits and detriments among women targeted by the Norwegian Breast Cancer Screening Program.
BMC Womens Health. 2022 Apr 27;22(1):132. doi: 10.1186/s12905-022-01718-w.
4
The role of philosophy and ethics at the edges of medicine.医学边缘的哲学与伦理学作用。
Philos Ethics Humanit Med. 2021 Nov 6;16(1):14. doi: 10.1186/s13010-021-00114-w.
5
Do we need the criminalization of medical fake news?是否需要将医疗假新闻定罪?
Med Health Care Philos. 2021 Jun;24(2):235-245. doi: 10.1007/s11019-020-09996-7. Epub 2021 Jan 4.
6
COVID-19 and the eye: how much do we really know? A best evidence review.新冠病毒与眼睛:我们究竟了解多少?一项最佳证据综述。
Arq Bras Oftalmol. 2020 Jun;83(3):250-261. doi: 10.5935/0004-2749.20200067. Epub 2020 May 29.
7
Too much medicine? Scientific and ethical issues from a comparison between two conflicting paradigms.用药过度?两种冲突范式的比较引发的科学和伦理问题。
BMC Public Health. 2019 Jan 22;19(1):97. doi: 10.1186/s12889-019-6442-9.
8
[Not Available].[无可用内容]
Aten Primaria. 2018 May;50 Suppl 1(Suppl 1):41-65. doi: 10.1016/S0212-6567(18)30362-7.
权衡挪威乳腺癌筛查计划目标人群中女性的利弊。
J Med Screen. 2016 Dec;23(4):203-209. doi: 10.1177/0969141315625088. Epub 2016 Mar 2.
4
PSYCHOLOGY. Estimating the reproducibility of psychological science.心理学. 心理科学可重复性的评估.
Science. 2015 Aug 28;349(6251):aac4716. doi: 10.1126/science.aac4716.
5
Conflict of interest disclosure and the polarisation of scientific communities.利益冲突披露与科学界的两极分化。
J Med Ethics. 2015 Apr;41(4):356-8. doi: 10.1136/medethics-2014-102114. Epub 2015 Jan 20.
6
Reproducibility in science: improving the standard for basic and preclinical research.科学可重复性:提高基础和临床前研究的标准。
Circ Res. 2015 Jan 2;116(1):116-26. doi: 10.1161/CIRCRESAHA.114.303819.
7
An open investigation of the reproducibility of cancer biology research.一项关于癌症生物学研究可重复性的公开调查。
Elife. 2014 Dec 10;3:e04333. doi: 10.7554/eLife.04333.
8
European breast cancer service screening outcomes: a first balance sheet of the benefits and harms.欧洲乳腺癌筛查服务的结果:收益与危害的首份资产负债表。
Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1159-63. doi: 10.1158/1055-9965.EPI-13-0320.
9
Breast cancer screening: time for rational discourse.
Cancer. 2014 Sep 15;120(18):2800-2. doi: 10.1002/cncr.28788. Epub 2014 Jun 12.
10
Who's afraid of peer review?谁害怕同行评审?
Science. 2013 Oct 4;342(6154):60-5. doi: 10.1126/science.2013.342.6154.342_60.